Status:
TERMINATED
Nickel Sensitivity
Lead Sponsor:
Rush University Medical Center
Conditions:
Knee Arthropathy
Allergic Reaction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare clinical outcomes of patients with self reported nickel sensitivity undergoing primary total knee arthroplasty (TKA) with conventional, standard-of-care vs nick...
Detailed Description
Metal implants are a mainstay of orthopedic treatment, and a variety of metal implants have been utilized for more than 40 years. Total knee replacement implants have been comprised of a variety of me...
Eligibility Criteria
Inclusion
- Patients undergoing primary TKA for the diagnosis of osteoarthritis or inflammatory arthritis with self-reported nickel allergy. Patients are routinely asked about nickel sensitivity as a part of the standard pre operative questionnaire already in place.
Exclusion
- Patients less than 18 years of age
- Patients undergoing revision TKA
- Non english speaking patients
- Patient who have medical comorbidities that prevent elective TKA
Key Trial Info
Start Date :
September 27 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 21 2024
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04058743
Start Date
September 27 2019
End Date
December 21 2024
Last Update
January 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University medical Center
Chicago, Illinois, United States, 60612